Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD-dominant cannabis oil for chronic insomnia
TCTR20230417005Phase 3Completed
- Sponsor
- Health Systems Research Institute
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in Insomnia, sponsored by Health Systems Research Institute. Started Mar 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
Insomnia
Beyond the preview
Go deeper on TCTR20230417005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230417005.